Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Clareto is a U.S. health data interoperability and insurtech company focused on providing electronic health record access and related data retrieval services for the life and disability insurance industry. Its core commercial offering, EHR+, is an interoperability network designed to help insurers obtain electronic medical data for underwriting, claims, and risk assessment workflows. The company originated from MedVirginia and built a network spanning EHRs, health information exchanges, and other clinical data sources. Clareto was acquired by MIB in May 2025 from Munich Re Life US, and its business is now positioned as part of a broader electronic medical data and analytics offering for life insurance customers. The company is not a drug developer and does not appear to operate a therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Clareto.